Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.

Kaplan–Meier survival analysis demonstrated a near-significant ( p = 0.0530) association of PFS with HLA class I expression detected by the HC10 antibody and a highly significant association ( p = 0.0025) with HLA class II expression ( Figure 3 a,b).

also in 132,142 other papers